Recent studies demonstrated a significant correlation between high levels of sCD163 and decreased insulin sensitivity in adipose tissue and circulating free fatty acid levels in NAFLD patients [27]. Here, CD163 is linked to metabolic dysfunction-associated steatotic liver disease.